Holen Sie sich die Stockscreener-App
5.59
0.18%
-0.010
Clinuvel Pharmaceuticals Limited American Depositary Shares Aktie (CUVL) Neueste Nachrichten
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - markets.businessinsider.com
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - GlobeNewswire
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - The Manila Times
Clinuvel Pharmaceuticals (ASX:CUV) Releases FY26 Report After Expanding U.S. Market Access - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV): US Expansion Strategy and Nasdaq Listing Transition - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Makes U.S. Pivot With Nasdaq Uplisting and Headquarters Shift Plan - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Greater US Exposure Trigger a Powerful New Growth Chapter? - Kalkine
Clinuvel Pharmaceuticals (CUVL) uplifts ADR to Level II ADS - Stock Titan
CLINUVEL Pharmaceuticals Completes Nasdaq Uplift with ADS Trading Launch Under CUVL Ticker - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Its New US Listing Transform Global Investor Interest? - Kalkine
CLINUVEL’s ADS to commence trading on Nasdaq - globenewswire.com
CLINUVEL Pharmaceuticals Launches American Depositary Shares on Nasdaq Global Select Market - Kalkine
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
IPO Calendar for: - Yahoo! Finance Canada
CLINUVEL’s ADS to commence trading on Nasdaq - Yahoo Finance
CLINUVEL expects Nasdaq trading; no new shares proposed - Stock Titan
CLINUVEL ADS to commence trading on Nasdaq - scanx.trade
Clinuvel (ASX:CUV) Eyes Nasdaq: What the 20-F Filing Means for CUV Shareholders - Kalkine
CLVLY SEC FilingsClinuvel Pharmaceuticals Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Clinuvl Phrmaceu (CLVLY) Stock Price, News & Analysis - Stock Titan
1.64%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):